Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $9.78 million. The enterprise value is -$37.09 million.

Market Cap	9.78M
Enterprise Value	-37.09M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

APRE has 12.38 million shares outstanding. The number of shares has increased by 46.20% in one year.

Current Share Class	12.38M
Shares Outstanding	12.38M
Shares Change (YoY)	+46.20%
Shares Change (QoQ)	+91.02%
Owned by Insiders (%)	11.42%
Owned by Institutions (%)	9.95%
Float	7.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	76.03
Forward PS	20.18
PB Ratio	0.23
P/TBV Ratio	0.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.92

Current Ratio	8.92
Quick Ratio	8.77
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.40% and return on invested capital (ROIC) is -26.57%.

Return on Equity (ROE)	-40.40%
Return on Assets (ROA)	-23.18%
Return on Invested Capital (ROIC)	-26.57%
Return on Capital Employed (ROCE)	-29.73%
Weighted Average Cost of Capital (WACC)	12.81%
Revenue Per Employee	$15,412
Profits Per Employee	-$1.49M
Employee Count	8
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.11% in the last 52 weeks. The beta is 1.56, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-56.11%
50-Day Moving Average	0.84
200-Day Moving Average	0.99
Relative Strength Index (RSI)	49.34
Average Volume (20 Days)	117,937

Short Selling Information

The latest short interest is 119,012, so 0.96% of the outstanding shares have been sold short.

Short Interest	119,012
Short Previous Month	147,564
Short % of Shares Out	0.96%
Short % of Float	1.61%
Short Ratio (days to cover)	0.62

Income Statement

In the last 12 months, APRE had revenue of $123,296 and -$11.95 million in losses. Loss per share was -$1.37.

Revenue	123,296
Gross Profit	-6.05M
Operating Income	-12.58M
Pretax Income	-11.95M
Net Income	-11.95M
EBITDA	-12.56M
EBIT	-12.58M
Loss Per Share	-$1.37

Full Income Statement

Balance Sheet

The company has $46.47 million in cash and n/a in debt, giving a net cash position of $46.47 million or $3.75 per share.

Cash & Cash Equivalents	46.47M
Total Debt	n/a
Net Cash	46.47M
Net Cash Per Share	$3.75
Equity (Book Value)	42.32M
Book Value Per Share	3.47
Working Capital	41.95M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.02M
Capital Expenditures	n/a
Depreciation & Amortization	21,714
Net Borrowing	n/a
Free Cash Flow	-12.02M
FCF Per Share	-$0.97

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-10,202.01%
Pretax Margin	-9,696.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.20%
Shareholder Yield	-46.20%
Earnings Yield	-127.54%
FCF Yield	-128.23%

Analyst Forecast

The average price target for APRE is $4.30, which is 444.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.30
Price Target Difference	444.30%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	91.63%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

APRE has an Altman Z-Score of -8.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.8
Piotroski F-Score	1